Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5630 Target Snapshot

1-deoxy-D-xylulose 5-phosphate reductoisomerase · SINGLE PROTEIN · Mycobacterium tuberculosis

166Compounds
23Assays
0Approved Drugs
130.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P9WNS1. Use UniProt P9WNS1 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P9WNS1 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 1-deoxy-D-xylulose 5-phosphate reductoisomerase as ChEMBL target CHEMBL5630, mapped to UniProt P9WNS1. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
1-deoxy-D-xylulose 5-phosphate reductoisomerase
SINGLE PROTEIN · Mycobacterium tuberculosis
As of 2026-09-14
ChEMBL target ID
CHEMBL5630
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P9WNS1
1-deoxy-D-xylulose 5-phosphate reductoisomerase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 1-deoxy-D-xylulose 5-phosphate reductoisomerase is the right protein anchor across sources, using UniProt P9WNS1 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label1-deoxy-D-xylulose 5-phosphate reductoisomerase
UniProt AccessionP9WNS1
Component TypeProtein
Sequence Length413 aa

1-deoxy-D-xylulose 5-phosphate reductoisomerase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 1-deoxy-D-xylulose 5-phosphate reductoisomerase, mapped to UniProt P9WNS1. Sequence length is 413 aa.

Mapped IDP9WNS1
Review name1-deoxy-D-xylulose 5-phosphate reductoisomerase
OrganismMycobacterium tuberculosis
Clinical Profile

Clinical Phase Distribution

3
Phase III
Assay Mix

Activity Type Distribution

IC50104.0
KI16.0
KD10.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2431008 8.04 IC50 9.2 Preclinical
CHEMBL203125 7.4 Kd 40.0 Clinical
CHEMBL2407192 7.4 Kd 40.0 Preclinical
CHEMBL2431007 7.38 IC50 42.0 Preclinical
CHEMBL203125 7.1 IC50 80.0 Clinical
CHEMBL2164257 7.1 IC50 80.0 Preclinical
CHEMBL2407187 7.05 Kd 90.0 Preclinical
CHEMBL2407189 7.05 Kd 90.0 Preclinical
CHEMBL4474216 7.0 IC50 100.0 Preclinical
CHEMBL2431010 6.96 IC50 110.0 Preclinical
Distribution

pChEMBL Value Distribution

14
5.0
18
5.5
9
6.0
21
6.5
11
7.0
0
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

23
Total Assays
96
Tested Compounds
1
Assay Types
Binding — 23 assays, 96 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 14 60 5.9
cell-based format 5 7 5.8
assay format 4 29 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine